Medicines losing patent protection

MonthYear

June 2027

5 medicines lose their last listed patent or exclusivity in June 2027.

Jun 1Balcoltraethinyl estradiol and levonorgestrel · Avion Pharmaceuticals LLC
Jun 13Lumiganbimatoprost · Abbvie Inc
Jun 26Prezista · Tablet (oral)darunavir · Janssen Products LP
Jun 26Prezista · Suspension (oral)darunavir · Janssen Products LP
Jun 28Paragard T 380Acopper · Coopersurgical Inc

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits